http://purl.org/np/RAvm8EuTud... RAvm8EuTud

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#wasAttributedTo wasAttributedTo

https://orcid.org/0000-0002-3668-2627 Elif Ozkan

Elif Ozkan

2022-10-13T13:25:29.979Z

http://purl.org/np/RAvm8EuTud... RAvm8EuTud

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#generatedAtTime generatedAtTime

2022-10-13T13:25:29.979788

Elif Ozkan

2022-10-13T13:25:29.979Z

http://purl.org/np/RAvm8EuTud... RAvm8EuTud

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#wasQuotedFrom wasQuotedFrom

Montelukast is indicated for: the prophylaxis and chronic treatment of asthma in adults and pediatric patients who are 12 months of age and older. It also includes indications for preventing day and night-time symptoms, and the treatment of acetylsalicylic acid-sensitive asthma. The relief of symptoms of seasonal allergic rhinitis in patients 2 years and older and perennial allergic.

Elif Ozkan

2022-10-13T13:25:29.979Z